Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3323545
Max Phase: Preclinical
Molecular Formula: C25H24N6O4S
Molecular Weight: 504.57
Molecule Type: Small molecule
Associated Items:
ID: ALA3323545
Max Phase: Preclinical
Molecular Formula: C25H24N6O4S
Molecular Weight: 504.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=N/NC(=O)Cn2nc(Cc3cccs3)n(/N=C/c3ccc(OC)cc3)c2=O)cc1
Standard InChI: InChI=1S/C25H24N6O4S/c1-34-20-9-5-18(6-10-20)15-26-28-24(32)17-30-25(33)31(23(29-30)14-22-4-3-13-36-22)27-16-19-7-11-21(35-2)12-8-19/h3-13,15-16H,14,17H2,1-2H3,(H,28,32)/b26-15+,27-16+
Standard InChI Key: OSLPHOBLTMWQIA-JQMRRPHZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 504.57 | Molecular Weight (Monoisotopic): 504.1580 | AlogP: 2.75 | #Rotatable Bonds: 10 |
Polar Surface Area: 112.10 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.65 | CX Basic pKa: 1.57 | CX LogP: 4.05 | CX LogD: 4.05 |
Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.26 | Np Likeness Score: -1.95 |
1. Ünver Y, Sancak K, Çelik F, Birinci E, Küçük M, Soylu S, Burnaz NA.. (2014) New thiophene-1,2,4-triazole-5(3)-ones: highly bioactive thiosemicarbazides, structures of Schiff bases and triazole-thiols., 84 [PMID:25063946] [10.1016/j.ejmech.2014.01.014] |
Source(1):